Biocompatibility and immunology in the encapsulation of islets of Langerhans (bioartificial pancreas)

International Journal of Artificial Organs

Volumn 19, Issue 4, 1996, Pages 251-257

  Zekorn, T D C ^a   Horcher, A ^a   Mellert, J ^b   Siebers, U ^a   Altug, T ^d   Emre, A ^d   Hahn, H J ^c   Federlin, K ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Bioartificial pancreas; Biocompatibility; Immunoisolation; Immunology; Islets of Langerhans; Microencapsulation; Transplantation

Indexed keywords

BIOLOGICAL ORGANS; ENCAPSULATION; IMMUNOLOGY;

BIO-ARTIFICIAL PANCREAS; FOREIGN BODY REACTIONS; HYDROGEL MATRIX; HYDROGEL MEMBRANE; IMMUNO-ISOLATION; INSULIN-DEPENDENT DIABETES; ISLETS OF LANGERHANS; MICROCAPSULES; ORGAN REPLACEMENT; TRANSPLANTATION;

BIOCOMPATIBILITY;

ANIMAL CELL; ARTICLE; ARTIFICIAL PANCREAS; BIOCOMPATIBILITY; DOG; ENCAPSULATION; IMMUNOLOGY; NONHUMAN; PANCREAS ISLET; RAT; SWINE; TRANSPLANTATION;

EID: 0029990166     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889601900408     Document Type: Article

References (34)

1. The diabetes control and complications trial research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM 1993; 329: 977-86.
2. Alejandro R, Feldman EC, Bloom AD, Kenyon NS. Effects of cyclosporin on insulin and C-peptide secretion in healthy beagles. Diabetes 1989; 38: 698-703.
3. Mandrup-Poulsen T, Bendtzen, K, Nerup J, Egeberg J, Nielsen, JH. Mechanisms of pancreatic islet cell destruction. Allergy 1986; 41: 250-9.
4. Lim F, Sun A. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210: 908-10.
5. Hackel U, Klein J, Megenet R, Wagner F. Immobilization of microbial cells in polymeric matrices. Eur J Appl Microbiol Biotechnol 1975, 1: 291-3.
6. Baardseth E. Localization and structure of alginate gels. In: Young EG, McLachlan JL, eds. Proceedings of the fifth international seaweed symposium. Oxford: Pergamon Press, 1965: 19-28.
7. Skjak-Braek G, Martinsen A. Applications of some algal polysaccharides in biotechnology. In: Guiry MD, Blunden G Seaweed resources in Europe: uses and potential. John Wiley & Sons Ltd. 1991. 219-57.
8. Zimmermann U, Klöck G, Federlin K, et al. Production of mitogen-contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis. Electrophoresis 1992; 13: 269-74.
9. Otterlei M, Ostgaard K, Skjak-Braek G, Smidsrod O, Soon-Shiong P, Espevik T. Induction of cytokine production from human monocytes stimulated with alginate. J Immunother. 1991; 10: 286-91.
10. Espevik T, Otterlei M, Skjak-Braek G, Ryan L, Wright SD, Sundan A. The involvment of CD 14 in stimulation of cytokine production by uronic polymers. Eur J Immunology 1993, 23:255-61.
11. Mai GT, Seow WK, Pier GB, McCormack JG, Thong YH. Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physiochemical, alginase, and specific monoclonal antibody treatments. Infection and Immunity 1993, 61: 559-64.
12. Zekorn T, Klöck G, Horcher A, et al. Lymphoid activation by different crude alginates and the effect of purification. Transpl Proc 1992; 24: 2952-3.
13. Fritschy WM, Wolters GHJ, van Schilfgaarde R Effect of alginate-polylysine-alginate microencapsualtion on in vitro insulin release from rat pancreatic islets. Diabetes 1991; 40: 37-43.
14. Cheetham PSJ, Garret C, Clark J. Isomaltulose production using immobilized cells. Biotechnol Bioeng 1985; 27: 471-80.
15. Christenson L, P Aebischer, P McMillan PM Galletti. Tissue reaction to intraperitoneal polymer implants: species difference and effects of corticoid and doxyrubicin. J Biomed Mater Res 1989, 23: 705-18.
16. Cole DR, Waterfall M, McIntre M, Baird JD. Microencapsulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure. Diabetologia 1992; 35: 231-37.
17. Penfornis F, Icard P, Gotheil C, et al. Bioartificial pancreas in pigs. Horm Metabol Res .1990; Suppl.25: 200-2.
18. Wtjsman J, Atkinson P, Mazaheri R, et al. Histological and immunopathological analysis of recovered encapsulated allogeneic islets from transplanted diabetic BB/ W rats. Transplantation 1992; 54: 588-92.
19. Siebers U, Sturm R, Planck H, et al. Morphological studies on biocompatibility of membranes for immunoisolated islet transplantion. Horm Metabol Res 1990; Suppl.25: 206-8.
20. Darqui S, Chicheportiche D, Capron F, Boitard C, Reach G. Comparative study of microencapsulated rat islets implanted in different diabetic models in mice. In: Federlin K, Bretzel RG, Hering BJ, eds. Methods in islet transplantation research. Horm Metabol Res 1990, Suppl. 25. 209-13.
21. Kroncke K-D, Funda J, Berschick B, Kolb H, Kolb-Bachofen V. Macrophage cytotoxicity towards isolated rat islet cells: neither lysis nor its protection by nicotinamide are beta-cell specific. Diabetologia 1991; 24: 232-8.
22. Darquy S, Pueyo ME, Capron F, Reach G. Complement activation by alginate-polylysine microcapsules used for islet transplantation. Artificial Organs 1994; 18: 898-903.
23. Wijsman J, Atkinson P, Mazaheri R, et al. Histological and immunopathological analysis of recovered encapsulated allogeneic islets from transplanted diabetic BB/ W rats. Transplantation 1992; 54: 588-92.
24. Horcher A, Zekorn T, Siebers U, et al. Transplantation of microencapsulated islets in rats: Evidence for induction of fibrotic overgrowth by islet allopantigens released from microcapsules. Transpl Proc (in press) presented at the 4th Intnat'l Congress on Pancreas and Islet Transplantation, Amsterdam, June 1993.
25. Zekorn T, Entenmann H, Horcher A, et al. Lymphoid activation by micro- and macroencapsulated islets during mixed-lymphocyte-islet-culture. Acta diabetologica (in press).
26. Zekorn TDC, Horcher A, Siebers U, et al. Bariumcross-linked alginate beads: A simple, one-step-method for successful immuno isolated transplantation of islets of Langerhans. Acta Diabetologica 1992; 29: 99-106.
27. Vandenbossche GMR, Bracke ME, Cuvelier CA, Bortier HE, Marbel MM, Remon J-P. Host reaction against alginate-polylysine microcapsules containing living cells. J Pharm Parmacol 1993; 45: 121-5.
28. Weber C, D'Agati V, Ward L, Costanzo M, Rajotte R, Reemtsma K. Humoral reaction to microencapsulated rat, canine, and porcine islet xenografts in spontaneously diabetic NOD mice. Transpl Proc 1993; 25: 462-3.
29. Platt JL, Lindman BJ, Chen H, Spitalnik SL, Bach FH. Endothelial cell antigens recognized by xenoreactive human natural antibodies. Transplantation 1990; 50: 817-22.
30. Ratner AJ, Canhui H, Pepino P, et al. Lymphocyte xenoantigens recognized by preformed antibodies. Transpl. Proc. 1992; 24: 583-5.
31. Weber C, Krekun S, Koschitzky T, et al. Prolonged functional survival of rat-to-NOD mouse islet xenografts by ultraviolet B (UV-B) irradiation plus microencapsulation of donor islets. Transpl Proc 1991; 24: 764-6.
32. Horcher A. Siebers U, Klöck G, et al. Graft function after transplantation of microencapsulated cultured islets: low-temperature culture before or after encapsulation? Horm metabol Res 1995; 27: 54 (abstract).
33. Soon-Shiong P, Feldman E, Nelson R, et al. Long-term reversal of diabetes by the injection of immunoprotected islets. Proc Natl Acad Sci USA 1993; 90: 5843-7.
34. Siebers U, Zekorn T, Horcher A, et al. Microencapsulated transplantation of allogeneic islets into specifically presensitized recipients. Transpl Proc 1994; 26: 787-8.